Skip to main content

Advertisement

Table 2 Concentration of low molecular weight urinary proteins in T2DM patients with and without secondary complications

From: Characterization of low molecular weight urinary proteins at varying time intervals in type 2 diabetes mellitus and diabetic nephropathy patients

Molecular weight in kDa Control (mg/dl) T2DM with 0–5 years (mg/dl) T2DM with 5–10 years (mg/dl) T2DM with 10–15 years (mg/dl) T2DM with 15–20 years (mg/dl) Micro albuminuria (mg/dl) Diabetic nephropathy (mg/dl) Non diabetic nephropathy (mg/dl)
13 1.5 3.01
NSa
12.37
***ab
18.11
***abc
26.82
***abcd
99.93
***abc,NSe
318.54
***abcdef
0.67
NSabcdefg
17 1.32 34.38
***a
32.89
***aNSb
32.62
***aNSbc
37.64
***aNSbcd
175.92
***abcde
217.48
**abcdef
0
NSabcdefg
23 15.42 15.42
NSa
16.76
NSab
17.81
NSabc
33.87
*aNSbcd
76.15
***abcd **e
158.39
*abcdef
0.32
NSabcdefg
24 2.42 5.42
NSa
7.69
NSab
7.88
NSabc
12.7
***a *bcd
51.29
***abcde
71.32
***abcdef
0
NSabcdefg
28 7.21 7.21
Nsa
7.56
NSab
9.63
NSabc
13.28
*abcNSd
109.35
***abcde
71.83
***abcdef
0.11
Nsabcdefg
35 1.94 3.65
Nsa
4.21
NSab
5.6
NSabc
6.44
NSabcd
45.68
***abcde
52.09
***abcdef
0
Nsabcdefg
37 1.25 7.52
*a
7.86
*aNSb
8.21
*aNSbc
12.23
***a *bcd
45.73
***abcde
69.43
***abcdef
0
NSabcdefg
39 0.09 2.11
NSa
2.2
NSab
2.45
NSabc
3.05
NSabcd
28.97
***abcde
41.83
***abcdef
0
NSabcdefg
41 8.48 22.15
**a
23.14 **aNSb 26.71
**aNSbc
26.24
**aNSbcd
149.25
***abcde
246.93
***abcdef
0
NSabcdefg
49 11.28 23.61
*a
23
*aNSb
23.57
*aNSbc
32.76
**a *bcd
214.62
***abcde
341.59
**abcdef
0.14
NSabcdefg
50 8.72 31.03 **a 31.5
**aNSb
32.6
**aNSbc
33.02
**aNSbcd
172.18
***abcde
216.61
**abcdef
0
NSabcdefg
  1. The results are expressed as mean + SE and p < 0.05 is considered significant. * p < 0.05, ** p < 0.001, *** p < 0.0001
  2. a—compared with control, b—compared with 0–5 years, T2DM, c—compared with 5–10 years T2DM, d—compared with 10–15 years T2DM, e—compared with 15–20 years T2DM, f—compared with microalbuminuria, g—compared with diabetic nephropathy
  3. NS, non significant